Clinical Trials
4
Active:1
Completed:3
Trial Phases
3 Phases
Phase 3:1
Phase 4:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)โข Click on a phase to view related trials
Not Applicable
1 (33.3%)Phase 3
1 (33.3%)Phase 4
1 (33.3%)AqueSys XEN 45 Glaucoma Implant in Refractory Glaucoma
Not Applicable
Completed
- Conditions
- GlaucomaGlaucoma, Open Angle
- First Posted Date
- 2014-01-15
- Last Posted Date
- 2017-06-01
- Lead Sponsor
- AqueSys, Inc.
- Target Recruit Count
- 65
- Registration Number
- NCT02036541
- Locations
- ๐บ๐ธ
George R. Reiss, MD PC, Glendale, Arizona, United States
๐บ๐ธVold Vision, Fayetteville, Arkansas, United States
๐บ๐ธMontebello Eye Center, Montebello, California, United States
Evaluation of the XEN Implant in Moderate Primary Open Angle Glaucoma (POAG) Participants
Phase 4
Completed
- Conditions
- Primary Open Angle Glaucoma
- First Posted Date
- 2013-12-10
- Last Posted Date
- 2019-04-22
- Lead Sponsor
- AqueSys, Inc.
- Target Recruit Count
- 199
- Registration Number
- NCT02006693
- Locations
- ๐ฆ๐น
University of Graz, Graz, Austria
๐ฆ๐นUniversity Augenklinik Salzburg, Salzburg, Austria
๐ฆ๐นVienna University, Vienna, Austria
AqueSys Microfistula Implant in Refractory Glaucoma
Phase 3
Completed
- Conditions
- Glaucoma, Open-AngleGlaucoma
- First Posted Date
- 2012-07-16
- Last Posted Date
- 2016-02-08
- Lead Sponsor
- AqueSys, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT01640756
- Locations
- ๐บ๐ธ
Vold Vision, PLLC, Fayetteville, Arkansas, United States
๐บ๐ธUSC Eye Institute, University of Southern California, Los Angeles, California, United States
๐บ๐ธScripps Clinic, San Diego, California, United States
News
No news found